Study of Pembrolizumab, Carboplatin, Paclitaxel, and Radiation for the Treatment of Early-Stage Anal Cancer
Clinical trial NCT06493019 · RECRUITING
Trial details
- NCT number
- NCT06493019
- Sponsor
- Dustin Deming
- Status
- RECRUITING
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2024-09-30
- Primary completion
- 2027-04-15
- Enrollment
- 23
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.